Status:
COMPLETED
Nicotine Substitute Prescribed at Hourly Intake or ad Libitum for Heavy Smokers Willing to Quit
Lead Sponsor:
University of Lausanne
Collaborating Sponsors:
Pharmacia
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Objective: To assess the impact of instructional guidance in the regular use of use nicotine nasal spray (NNS) on the true use of NNS during the first three weeks of smoking cessation for heavy smoker...
Eligibility Criteria
Inclusion
- Highly dependent smokers in the stage of preparation according to Prochaska and Di Clemente's stages of change model
Exclusion
- History of myocardial infarction in the preceding 3 months
- Pregnancy or breast-feeding
- Use of any form of smokeless tobacco or other nicotine replacement therapy
Key Trial Info
Start Date :
June 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2001
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00861276
Start Date
June 1 2000
End Date
December 1 2001
Last Update
March 13 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ambulatory Care and Community Medicine
Lausanne, Canton of Vaud, Switzerland, 1011